A lung cancer drug developed by Akeso Inc. extended patients’ lives by about four months in a late-stage trial in China, ...

CHICOPEE, Mass. (WWLP) – World Lung Cancer Day has been observed every year on August 1 since 2012 to raise awareness about the risk of the disease. Cooler start to August in western Massachusetts The ...

Survival rates for stage 3 lung cancer can vary between 13% to 36% depending on the subtype. Stage 3a lung cancer is often treated with surgery and medicines before or after surgery. Stage 3b and 3c ...

Thanks to recent therapy advances, the lung cancer mortality rate has declined and survival rates have improved. Many factors influence the likelihood of a lung cancer cure or long-term survival, ...

Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...

Lung cancer is classified into non-small cell and small cell types, influencing treatment strategies and prognosis. Advances in targeted therapies, immunotherapy, and minimally invasive surgeries have ...

A lung cancer diagnosis doesn’t just affect your health. It can make your work and finances uncertain. You may suddenly be wondering: Can I keep working? Do I need to tell my boss? What happens if ...

The U.S. Food and Drug Administration on Friday approved an Amgen Inc drug for non-small cell lung cancer with a specific mutation in a gene known as KRAS in patients whose disease has worsened after ...